C4 Therapeutics
CCCC
#7644
Rank
โ‚ฌ0.26 B
Marketcap
3,78ย โ‚ฌ
Share price
2.73%
Change (1 day)
-6.45%
Change (1 year)

Revenue for C4 Therapeutics (CCCC)

Revenue in 2024 (TTM): โ‚ฌ30.71 Million

According to C4 Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ32.25 Million. In 2023 the company made a revenue of โ‚ฌ18.77 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ28.98 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for C4 Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ30.71 M63.6%
2023 โ‚ฌ18.77 M-35.23%
2022 โ‚ฌ28.98 M-28.29%
2021 โ‚ฌ40.42 M49.8%
2020 โ‚ฌ26.98 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA